A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

计划入组 540 人 · 首次发布于 2010 年 9 月 13 日

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions

计划入组 38 人 · 首次发布于 2009 年 8 月 17 日

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

计划入组 24 人 · 首次发布于 2009 年 8 月 17 日

GPR119 agonists (Schering-Plough)

Levonorgestrel/Estrogen(Bayer Schering)

Ethinylestradiol/Gestodene(Bayer Schering)

Schering AG

Germany

Schering-Plough Canada Inc.

Canada

Schering Plough A/S

Denmark

Glenmark Pharmaceuticals Reaches $7M Settlement in US Antitrust Lawsuits Over Cholesterol Drugs

Strides Pharma Secures USFDA Approval for Generic Theophylline Extended-Release Tablets

Regeneron Pharmaceuticals: A Deep Dive into the Leadership and Commercial Infrastructure Behind a Biopharma Powerhouse